weaning off semaglutide Stopping Semaglutide: How to Prevent Rebound Weight Gain Weight-loss: Are injections the answer

Both medications showed no increased serious adverse events in seniors, though nausea and vomiting rates were slightly higher (28% vs 24% for tirzepatide)

Regulation of short-chain fatty acids in the immune system

Data from clinical trials have been very promising on this front, but its reassuring to see that these medications are also useful in clinical settings that arent as highly controlled as clinical trials. White said future research should analyze predictors for weight loss in people with diabetes to better understand who would best respond to a GLP-1 agonist and examine changes in body weight for adults who are fully adherent to GLP-1 therapy

Still, its difficult to know just how many people are using peptide therapy today